In this review, we have assembled several studies that have evaluated the use of cystatin C to assess glomerular filtration rate in patients with chronic kidney disease, diabetes mellitus and hemodialysis, and also the use of cystatin C to predict the risk of cardiovascular outcomes.
Until now, there is still no ideal biomarker to evaluate glomerular filtration rate, and cystatin C has been demonstrated to be a very promising one. Instituição: Departamento de Análises Clínicas e Toxicológicas, Faculdade de Farmácia, Campus Centro Oeste Dona Lindu – Universidade Federal de São João Del Rei – Divinópolis – MG, Brasil.Ĭonflito de interesse: sem conflito de interesse.Īccurate evaluation of the progression of renal function decline is very important, since the early establishment of renoprotective therapies can prevent or delay the occurrence of end stage renal disease. Departamento de Análises Clínicas e Toxicológicas, Faculdade de Farmácia, Campus Centro Oeste Dona Lindu – Universidadeįederal de São João Del Rei – Divinópolis – MG, Brasil. Cistatina C: um biomarcador promissor para a avaliação da função renalġ Graduada em Farmácia – Campus Centro Oeste Dona Lindu – Universidade Federal de São João Del Rei – Divinópolis – MG, Brasil.Ģ Departamento de Análises Clínicas e Toxicológicas, Faculdade de Farmácia, Universidade Federal de Minas Gerais – Belo Horizonte –ģ Doutor.
0 kommentar(er)
